Dassault Systèmes (US) launched an ‘Emma’ avatar for its digital twin technology to raise awareness regarding health research.
The digital twins in healthcare market is witnessing one of the fastest growth trajectories across the global health technology landscape. Valued at US$2.69 billion in 2024, the market expanded to US$4.47 billion in 2025 and is projected to grow at an exceptional CAGR of 68.0% from 2025 to 2030, reaching a staggering US$59.94 billion by the end of the forecast period.
This explosive growth reflects the healthcare industry’s shift toward data-driven, predictive, and personalized care models.
Digital twins — virtual replicas of physical entities such as patients, organs, devices, or healthcare systems — are transforming how diseases are understood, diagnosed, and treated. Powered by artificial intelligence (AI), machine learning (ML), big data analytics, and the Internet of Things (IoT), digital twins are enabling real-time simulation, forecasting, and optimization across the healthcare value chain.
Download PDF Brochure
Key Drivers Accelerating Market Growth
Expanding Applications of Digital Twins in Healthcare
The growing applications of digital twins are the most powerful driver of market growth. Digital twins allow healthcare providers to create dynamic, continuously updated virtual representations of patients by integrating physiological data, genetic information, medical history, lifestyle patterns, and environmental factors.
These virtual models are fed with real-time data from wearable sensors, connected medical devices, and electronic health records (EHRs).
By leveraging AI and ML algorithms, digital twins analyze massive datasets to identify trends, predict disease progression, and flag potential health risks before they become critical. This capability is transforming precision medicine, enabling more accurate diagnoses, targeted therapies, and personalized treatment plans.
Digital twins are also used to model organs, tissues, and even single cells, supporting advanced research in genomics, proteomics, and molecular biology. At an individual level, they help patients monitor chronic conditions such as diabetes, cardiovascular disease, and respiratory disorders, empowering proactive healthcare decisions and improving long-term outcomes.
Role of AI, IoT, and Advanced Analytics
Technological advancements play a central role in scaling digital twins in healthcare. AI and machine learning enhance the predictive accuracy of digital twins by interpreting complex, multi-source data.
Meanwhile, IoT-enabled devices continuously stream real-time patient data — such as blood pressure, oxygen saturation, heart rate, and glucose levels — into digital twin platforms.
This convergence enables remote patient monitoring, faster clinical decision-making, and early intervention, particularly valuable in managing chronic diseases and aging populations. As healthcare data becomes more accessible from providers, payers, and connected ecosystems, digital twins are evolving into essential tools for both clinical and operational optimization.
Restraint: Data Quality, Privacy, and High Implementation Costs
Despite their transformative potential, digital twins face challenges related to data quality, privacy, and cost. Digital twin systems rely on accurate, consistent, and high-quality data from multiple sources.
Any gaps, inconsistencies, or inaccuracies in data can compromise the reliability of simulations and predictions, directly impacting patient care.
Data privacy is another major concern, as digital twins handle highly sensitive personal health information. Healthcare organizations must implement robust data governance frameworks, cybersecurity measures, and compliance protocols to ensure data security and regulatory adherence.
Additionally, the initial implementation of digital twins can be expensive, requiring advanced hardware, specialized software, cloud infrastructure, and large-scale data storage systems. However, as adoption increases and technologies mature, implementation costs are expected to decline, making digital twins more accessible to a broader range of healthcare organizations.
Opportunity: Rising Adoption in Emerging Economies
Emerging economies are creating significant growth opportunities for the digital twins in healthcare market. Countries such as Japan, China, and Singapore are investing heavily in digital health innovation to improve healthcare efficiency and population health outcomes.
In Japan, Tohoku University collaborated with Fujitsu Limited in 2022 to develop digital twins for optimizing health services. Similarly, Takeda Pharmaceutical and PwC Consulting launched a digital twin simulator for Crohn’s disease, highlighting the technology’s role in disease modeling and treatment optimization.
The National Center for Neurology and Psychiatry partnered with NTT Corporation to develop brain bio-digital twin technology aimed at detecting and preventing mental illnesses. In Singapore, SingHealth is using digital twins to predict disease outbreaks and optimize healthcare resources, underscoring the technology’s value at a population health level.
Challenge: Lack of Skilled Personnel
A critical challenge limiting adoption is the shortage of skilled professionals capable of designing, implementing, and managing digital twin systems. These technologies require expertise in data science, AI, machine learning, software engineering, and healthcare informatics.
The healthcare sector, already burdened with large volumes of unstructured data, often lacks the specialized workforce needed to fully leverage digital twins.
Without adequate talent, organizations may face higher costs, longer implementation timelines, and underutilization of digital twin capabilities. Addressing this challenge will require investments in workforce training, cross-industry collaboration, and partnerships with academic institutions to build future-ready skill sets.
Personalized Medicine: Fastest-Growing Application Segment
By application, personalized medicine is expected to grow at the highest CAGR during the forecast period. Advances in genomics, molecular diagnostics, and precision medicine are driving demand for digital twins that can simulate individual patient responses to treatments.
Digital twins enable clinicians to test multiple therapeutic scenarios virtually, identify the most effective treatment with minimal side effects, and continuously refine care plans based on real-world patient data. This significantly improves treatment effectiveness, patient safety, and clinical outcomes.
Request Sample Report
Healthcare Providers Lead End-User Adoption
By end user, healthcare providers accounted for the largest share of the digital twins in healthcare market in 2024. Hospitals and care centers are increasingly using digital twins to enhance diagnostics, support telehealth, and improve clinical training.
Digital twins enable virtual consultations, remote diagnosis, and treatment planning without requiring in-person visits. They are also used for surgical planning, allowing surgeons to simulate procedures and outcomes using patient-specific anatomical models.
Additionally, healthcare providers use digital twins to train doctors and nurses on complex procedures, improving skill development and patient safety.
Regional Insights: North America at the Forefront
North America dominated the digital twins in healthcare market in 2024, driven by strong government funding, advanced healthcare infrastructure, and the presence of major technology and healthcare companies. The region is home to leading providers such as IBM, Microsoft, Ansys, Twin Health, Unlearn.AI, and Verto.
Major healthcare and industrial players, including Johnson & Johnson and Siemens, are actively partnering with startups to explore new digital twin applications, further accelerating adoption.
Conclusion
The digital twins in healthcare market is redefining how care is delivered, shifting the industry toward predictive, personalized, and proactive healthcare models. While challenges related to data quality, privacy, cost, and talent remain, rapid technological advancements and growing adoption across regions and applications are unlocking unprecedented opportunities.
As healthcare systems worldwide prioritize precision medicine, virtual clinical trials, and remote care, digital twins are set to become a foundational technology shaping the future of global healthcare.
News From
MarketsandMarkets™
Category: Industry Reports & Market Analysis Profile: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, w …
This email address is being protected from spambots. You need JavaScript enabled to view it.
